The flow cytometry results of the present study comparing control and IL-6 treated MDA-MB-231 cells suggest that IL-6 also promotes the synthesis of sLex on breast cancer cells, potentially providing more opportunity for sLex: E-selectin mediated heterotypic interaction between cancer cells and the activated endothelium. Here, IL6 is linked to breast cancer.